Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
GoldNX Sets New Standard in Secure Crypto Trading for Global Investors
-
Kinterra Capital Submits Proposal to Acquire 100% of New World Resources
-
IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy of Neurology (EAN)
-
Minjee Lee Wins KPMG Women's PGA Championship With a Callaway Elyte Driver, Callaway Chrome Tour X Golf Ball, and an Odyssey Ai-ONE Square 2 Square Putter
-
Risen Energy Highlights Advancements in Green Manufacturing, Sustainable Development and Corporate Responsibility in 2024 ESG Report
-
Sunwoda Highlights Utility-Scale and C&I Energy Storage Strategies for African Markets at AEF 2025
-
Govihair Marks Over Two Decades as a Trusted Vietnamese Hair Brand in the Global Market
-
Author Laurence Neal Pokras Announces Release of "My Socially Hazardous Life"
-
Blockchain Alliance International Launches Asia-Pacific Digital Economy Initiative in Hong Kong
-
WNP Launches All-in-One Hyaluronic Acid Skincare Set, Pioneering a "3-Step Scientific Skincare Method"
-
Luxury Dog Care Brand Pawmenities Announces Expansion of Premier Boarding and Daycare Services in Boston
-
Trinsec7 Launches Affordable Cybersecurity Solutions for Families, Bridging the Gap Between Enterprise Protection and Home Security
-
CODI Investors Have the Opportunity to Lead the Compass Diversified Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
ZA Miner Unveils 2025 Dogecoin & Ethereum Cloud Mining Event
-
ZA Miner Unveils 2025 Dogecoin & Ethereum Cloud Mining Event
-
Faraday Future Founder and Co-CEO, YT Jia, Shares Weekly Investor Update - FX Pushes “Scenario-as-Store” Frontier, Signs 500-Unit Deposit Agreement with Leading MCN Telling Inc., FX Super One B2B
-
Sequa Petroleum N.V. Update
-
2025 Travelers Championship Generates More Than $4 Million for Charity
-
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers
-
NEL Animal Cardiovascular Center Achieves World’s First Surgical Correction of Complex VSD in Canine Patient
-
Loop Industries Announces $1.5 Million Engineering Services Agreement for Infinite Loop India Project
-
Treeline Global Secures 25-Year Mandate to Deploy $6.2 Trillion Scientific Framework; Additional Strategic Systems Announced
-
Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Krispy Kreme, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DNUT
-
McLaren Health Care Data Breach Alert Issued By Wolf Haldenstein
-
Renesas Announces Expected Loss Resulting from Signing Restructuring Support Agreement with Wolfspeed
-
Wolfspeed Takes Proactive Step to Strengthen Financial Foundation Anticipating Scalable, Profitable Growth
-
New Data Show Delve Bio’s Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing
-
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
-
Tigo Energy and BayWa r.e. Empower High-Wattage C&I Solar in Thailand
-
Shift4 to Acquire Australian Payments Leader Smartpay
-
Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes
-
NSSC FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action - NSSC
-
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV
-
News Corp Extends Contract with Chief Executive Robert Thomson
-
Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer
-
CODI DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - CODI
-
PFMCrypto Launches Revolutionary XRP Mining Contracts, Igniting Market Enthusiasm
-
CAR DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 24 Deadline in Securities Class Acti
-
CIVI DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important July 1 Deadline in Securities Class Action - CIVI
-
RDDT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reddit, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CODI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Diversified Holdings Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
NSSC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that NAPCO Security Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
-
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
-
Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DDD
-
Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials
